Sugammadex
- Product NDC
- 83301-0078
- Requested package NDC
- 83301-0078-2
- 11-digit product format
- 833010078
- Labeler code
- 83301
- Product ID
- 83301-0078_7e2e6873-a8ed-4f4f-836f-30c7ccadd92c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SUGAMMADEX SODIUM
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Mullan Pharmaceutical Inc.
- Application
- ANDA215701
- Marketing category
- ANDA
- Marketing start
- 2026-11-02
- Substance
- SUGAMMADEX SODIUM
- Active strength
- 500 mg/5mL
- Pharmacologic classes
- gamma-Cyclodextrins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215701-001 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 | |
| A215701-002 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215701-001 | AP |
| A215701-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A215701-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A215701-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A215701-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A215701-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-10-06 | c2088c7a36db… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A215701-001 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A215701-002 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A215701-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A215701-002 | AP | 1 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sugammadex
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SUGAMMADEX SODIUM | 500 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ERJ6X2MXV7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5373abf1-c6ef-4295-9b2e-b07964b2fe37 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sugammadex | SUGAMMADEX SODIUM | Mullan Pharmaceutical Inc. | 5373abf1-c6ef-4295-9b2e-b07964b2fe37 | 2026-11-02 | Warnings, Adverse reactions | 215701 ANDA215701 83301-0078-2 83301-0078 83301007802 |
| Sugammadex | SUGAMMADEX | Shandong New Time Pharmaceutical Co., Ltd. | 56400560-a2df-4126-b424-9e4b91e53a8b | 2025-03-24 | Warnings, Adverse reactions | 215701 ANDA215701 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 83301-0078-2 | 83301007802 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83301-0078-2) / 5 mL in 1 VIAL, SINGLE-DOSE (83301-0078-1) | 2026-11-02 | No | No | Current |